Maroc - 
SEBI faces criticism over ICICI Bank's acquisition of ICICI Securities. Shareholders allege unfair terms and seek clarity on regulatory exemptions.
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Articles similaires
Why Sebi is facing criticism over ICICI Securities, ICICI Bank merger
hindustantimes.com - 02/Sep 03:43
SEBI faces criticism over ICICI Bank's acquisition of ICICI Securities. Shareholders allege unfair terms and seek clarity on regulatory exemptions.
Go First insolvency case: Promoters asked to reply on liquidation in 3 weeks by NCLT
hindustantimes.com - 05/Sep 02:59
The NCLT has ordered the suspended board of Go First to respond within three weeks regarding the company's liquidation.
Go First insolvency case: Promoters asked to reply on liquidation in 3 weeks by NCLT
hindustantimes.com - 05/Sep 02:59
The NCLT has ordered the suspended board of Go First to respond within three weeks regarding the company's liquidation.
Pharma Stock Roundup: LLY Offers Cheap Zepbound, EU Okays Some Drugs
zacks.com - 30/Aug 15:35
LLY launches a discounted version of Zepbound. European Commission approves JNJ's Balversa, MRK's Winrevair and RHHBY's PiaSky.
Les derniers communiqués
-
Aucun élément